[18FDG in the primary staging of lung tumors. Results with a gamma camera and a 511 keV collimator]. 1995

L Trampert, and L H Holle, and R Berberich, and C Alexander, and D Ukena, and T Ruth, and G W Sybrecht, and E Oberhausen
Abteilung für Nuklearmedizin, Universitätskliniken Homburg/Saar, FRG.

The diagnosis of primary lung tumors requires a precise staging according to the TNM classification. In contrast to established imaging methods 18FDG describes the functional metabolic processes in the tumor tissue due to increased glycolysis. This paper describes the use of 18FDG in the primary staging of lung tumors and metastases. 44 patients were studied with a gamma camera and a 511 keV collimator. In comparison to pulmonary tumors and metastases detected by other imaging methods (107) the accumulation of 18FDG has a sensitivity of 85%, in lesions verified by histology (50) of 89%, in primary tumors (35) of 100% and in metastases (63) of 76%. As an alternative to FDG PET studies, primary staging of lung tumors is possible with a gamma camera, suitable for ECT and fitted with a 511 keV collimator.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D003847 Deoxyglucose 2-Deoxy-D-arabino-hexose. An antimetabolite of glucose with antiviral activity. 2-Deoxy-D-glucose,2-Deoxyglucose,2-Desoxy-D-glucose,2 Deoxy D glucose,2 Deoxyglucose,2 Desoxy D glucose
D005462 Fluorine Radioisotopes Unstable isotopes of fluorine that decay or disintegrate emitting radiation. F atoms with atomic weights 17, 18, and 20-22 are radioactive fluorine isotopes. Radioisotopes, Fluorine
D005720 Gamma Rays Penetrating, high-energy electromagnetic radiation emitted from atomic nuclei during NUCLEAR DECAY. The range of wavelengths of emitted radiation is between 0.1 - 100 pm which overlaps the shorter, more energetic hard X-RAYS wavelengths. The distinction between gamma rays and X-rays is based on their radiation source. Gamma Wave,Gamma Radiation,Nuclear X-Rays,Radiation, Gamma,X-Rays, Nuclear,Gamma Radiations,Gamma Ray,Gamma Waves,Nuclear X Rays,Nuclear X-Ray,Ray, Gamma,Wave, Gamma,Waves, Gamma,X Rays, Nuclear,X-Ray, Nuclear
D006019 Glycolysis A metabolic process that converts GLUCOSE into two molecules of PYRUVIC ACID through a series of enzymatic reactions. Energy generated by this process is conserved in two molecules of ATP. Glycolysis is the universal catabolic pathway for glucose, free glucose, or glucose derived from complex CARBOHYDRATES, such as GLYCOGEN and STARCH. Embden-Meyerhof Pathway,Embden-Meyerhof-Parnas Pathway,Embden Meyerhof Parnas Pathway,Embden Meyerhof Pathway,Embden-Meyerhof Pathways,Pathway, Embden-Meyerhof,Pathway, Embden-Meyerhof-Parnas,Pathways, Embden-Meyerhof
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

L Trampert, and L H Holle, and R Berberich, and C Alexander, and D Ukena, and T Ruth, and G W Sybrecht, and E Oberhausen
January 1992, European journal of nuclear medicine,
L Trampert, and L H Holle, and R Berberich, and C Alexander, and D Ukena, and T Ruth, and G W Sybrecht, and E Oberhausen
July 1999, Physics in medicine and biology,
L Trampert, and L H Holle, and R Berberich, and C Alexander, and D Ukena, and T Ruth, and G W Sybrecht, and E Oberhausen
January 1992, European journal of nuclear medicine,
L Trampert, and L H Holle, and R Berberich, and C Alexander, and D Ukena, and T Ruth, and G W Sybrecht, and E Oberhausen
February 1995, Nuklearmedizin. Nuclear medicine,
L Trampert, and L H Holle, and R Berberich, and C Alexander, and D Ukena, and T Ruth, and G W Sybrecht, and E Oberhausen
March 1981, Journal of medical engineering & technology,
L Trampert, and L H Holle, and R Berberich, and C Alexander, and D Ukena, and T Ruth, and G W Sybrecht, and E Oberhausen
September 1996, Radiographics : a review publication of the Radiological Society of North America, Inc,
L Trampert, and L H Holle, and R Berberich, and C Alexander, and D Ukena, and T Ruth, and G W Sybrecht, and E Oberhausen
August 2014, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine,
L Trampert, and L H Holle, and R Berberich, and C Alexander, and D Ukena, and T Ruth, and G W Sybrecht, and E Oberhausen
February 1972, Radiology,
L Trampert, and L H Holle, and R Berberich, and C Alexander, and D Ukena, and T Ruth, and G W Sybrecht, and E Oberhausen
February 1985, Nuklearmedizin. Nuclear medicine,
L Trampert, and L H Holle, and R Berberich, and C Alexander, and D Ukena, and T Ruth, and G W Sybrecht, and E Oberhausen
March 1990, Nuklearmedizin. Nuclear medicine,
Copied contents to your clipboard!